首页> 外文期刊>Journal of chromatography, A: Including electrophoresis and other separation methods >Liquid chromatography-tandem mass spectrometry method for the quantification of mycophenolic acid and its phenolic glucuronide in saliva and plasma using a standardized saliva collection device
【24h】

Liquid chromatography-tandem mass spectrometry method for the quantification of mycophenolic acid and its phenolic glucuronide in saliva and plasma using a standardized saliva collection device

机译:液相色谱-串联质谱法使用标准化唾液收集装置定量分析唾液和血浆中的麦考酚酸及其酚醛葡萄糖醛酸

获取原文
获取原文并翻译 | 示例
           

摘要

A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed for simultaneous quantification of mycophenolic acid (MPA) and its phenolic glucuronide (MPAG) in saliva and plasma. Saliva was collected and processed using a standardized commercially available collection device. Sample preparation comprised of protein precipitation with acetonitrile and subsequent centrifugation, followed by evaporation and reconstitution with mobile phase. A labeled isotope of MPA was used as internal standard, and chromatographic separation was achieved on a C18 column with an isocratic flow. LC-MS/MS detection was performed using a triple-stage quadrupole mass spectrometer working in selected reaction monitoring mode with positive electrospray ionization (ESI). The analytes were quantified in a single run within 2. min. For saliva, linearity was demonstrated over the concentration range of 5.0 to 400.0. ng/ml for both MPA and MPAG, and from 0.08 to 20.00. μg/ml for MPA and 0.4 to 100.0. μg/ml for MPAG in plasma. The lower limits of quantification for MPA and MPAG were 0.07 and 0.80. ng/ml in saliva, and 0.002 and 0.009. μg/ml in plasma, respectively. Inter- and intra-day precisions expressed as relative standard deviation (RSD) and accuracies were less than 15%. The recoveries for MPA and MPAG from the collection device's swab were higher than 90%. Sample stability was confirmed for bench times up to 24. h at room temperature. The method was validated according to International Conference on Harmonization (ICH) guidelines Q2 (R1) Validation of Analytical Procedures. The applicability of the method was tested in a renal pediatric patient. Based on a limited sampling strategy, MPA saliva and plasma concentrations were found in good agreement with each other. We suggest that the described method is suitable to analyze saliva and plasma samples of small volumes for therapeutic drug monitoring (TDM) and pharmacokinetic studies in pediatric patients.
机译:建立了液相色谱-串联质谱(LC-MS / MS)方法,用于同时定量唾液和血浆中的麦考酚酸(MPA)及其酚醛葡糖醛酸(MPAG)。使用标准化的市售收集设备收集并处理唾液。样品制备包括用乙腈沉淀蛋白质,随后离心,然后蒸发并用流动相复溶。 MPA的标记同位素用作内标,并在等度流动的C18色谱柱上完成色谱分离。 LC-MS / MS检测是使用三级四极质谱仪在选定的反应监测模式下进行的,并采用正电喷雾电离(ESI)。在2分钟内一次运行即可定量分析物。对于唾液,在5.0至400.0的浓度范围内表现出线性关系。 ng / ml(对于MPA和MPAG),范围从0.08到20.00。 MPA的微克/毫升和0.4至100.0。血浆中MPAG的微克/毫升。 MPA和MPAG的定量下限为0.07和0.80。唾液中的ng / ml,以及0.002和0.009。血浆中微克/毫升。以相对标准偏差(RSD)和精确度表示的日间和日间精度小于15%。从采集设备的棉签中回收的MPA和MPAG高于90%。在室温下长达24 h的工作时间中,样品稳定性得到确认。该方法已根据国际协调会议(ICH)指南Q2(R1)分析程序验证进行了验证。该方法的适用性在肾小儿患者中进行了测试。基于有限的采样策略,发现MPA唾液和血浆浓度彼此高度吻合。我们建议,所描述的方法适用于分析小剂量的唾液和血浆样本,以用于儿科患者的治疗药物监测(TDM)和药代动力学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号